Dashboard
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Poor long term growth as Operating profit has grown by an annual rate -13.73% of over the last 5 years
3
Flat results in Dec 24
4
Risky -
5
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-85.0%
0%
-85.0%
6 Months
-86.0%
0%
-86.0%
1 Year
-89.23%
0%
-89.23%
2 Years
-91.31%
0%
-91.31%
3 Years
-97.94%
0%
-97.94%
4 Years
-99.22%
0%
-99.22%
5 Years
-97.39%
0%
-97.39%
ANGLE Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
25.47%
EBIT Growth (5y)
-13.73%
EBIT to Interest (avg)
-18.15
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.52
Sales to Capital Employed (avg)
0.07
Tax Ratio
5.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.76
EV to EBIT
-0.27
EV to EBITDA
-0.30
EV to Capital Employed
0.61
EV to Sales
1.70
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-226.27%
ROE (Latest)
-134.94%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
Bollinger Bands
Sideways
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'22
Dec'22
Dec'21
Change(%)
Net Sales
1.00
1.00
Operating Profit (PBDIT) excl Other Income
-23.30
-15.90
-46.54%
Interest
0.40
0.20
100.00%
Exceptional Items
-0.80
-0.00
Consolidate Net Profit
-21.70
-15.00
-44.67%
Operating Profit Margin (Excl OI)
-24,269.90%
-17,145.10%
-712.48%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2022 is 0.00% vs 25.00% in Dec 2021
Consolidated Net Profit
YoY Growth in year ended Dec 2022 is -44.67% vs -29.31% in Dec 2021
About ANGLE Plc 
ANGLE Plc
Retailing
ANGLE plc is a holding company. The Company's principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The resulting liquid biopsy (blood test) enables the detection and investigation of mutations in the patient's cancer for personalized cancer care. The harvested CTCs have a range of applications, including diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring.
Company Coordinates 
Company Details
The Surrey Research Park, 10 Nugent Road , GUILDFORD None : GU2 7AF
Registrar Details






